PV-0623 Tumor-stroma ratio for predicting pathologic response after chemoradiotherapy in esophageal cancer

Authors :: Jurjen J. Boonstra
Wilma E. Mesker
G W van Pelt
D. van Klaveren
J.A. Krol
A. Farina Sarasqueta
I.M. Lips
Marije Slingerland
W.O. de Steur
Femke P. Peters
Source :: Radiotherapy and Oncology. 133:S331-S332
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Pathology
medicine.medical_specialty
Oncology
business.industry
Medicine
Pathologic Response
Radiology, Nuclear Medicine and imaging
Hematology
Esophageal cancer
business
Tumor stroma
medicine.disease
Chemoradiotherapy

Full Text Access

Tools